Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT00321191
Registration number
NCT00321191
Ethics application status
Date submitted
2/05/2006
Date registered
3/05/2006
Date last updated
24/06/2015
Titles & IDs
Public title
Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients
Query!
Scientific title
Measurement of the Second Gas Effect on Sevoflurane in Anaesthetised Patients
Query!
Secondary ID [1]
0
0
02531
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Anesthesia
0
0
Query!
Condition category
Condition code
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - No nitrous oxide
Treatment: Drugs - Administration of N2O
Experimental: N2O -
Placebo Comparator: No N2O -
Treatment: Drugs: No nitrous oxide
Treatment: Drugs: Administration of N2O
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Fa/FI sevoflurane in 100% O2 vs in 70% N2O and 30% O2 during 1st 60 min anaesthesia
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Primary outcome [2]
0
0
Change in Fa/FI sevoflurane in 100% O2 vs in 70% N2O and 30% O2 after 60 minutes anaesthesia
Query!
Assessment method [2]
0
0
Query!
Timepoint [2]
0
0
Query!
Secondary outcome [1]
0
0
Fa/FI and FA/FI for N2O will also be recorded.
Query!
Assessment method [1]
0
0
Query!
Timepoint [1]
0
0
Query!
Eligibility
Key inclusion criteria
- Patients scheduled for elective surgery requiring relaxant general anaesthesia with
arterial blood pressure monitoring via an arterial line.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion criteria:
- Patients with moderately or severely impaired respiratory disease (FEV1 < 1.5L, or FVC
< 2.0L).
- Patients under 18 years of age.
- Morbidly obese patients: BMI > 30
- Patients unable to give informed consent.
Query!
Study design
Purpose of the study
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/05/2006
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/09/2006
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
14
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Austin Hospital - Melbourne
Query!
Recruitment postcode(s) [1]
0
0
3084 - Melbourne
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Austin Health
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This study is investigating the "second gas effect", a phenomenon produced by the uptake of
nitrous oxide (N2O) by the lungs, during the course of a typical anaesthetic. The effect is
to increase the concentration of other breathed gases in the lung. These include oxygen and
volatile anaesthetic agents such as sevoflurane, which are also normally administered along
with N2O. We wish to i) measure the magnitude of the second gas effects on both blood and
expired concentrations of sevoflurane (Part 1), and ii) see if a demonstrable difference
exists between the effects on blood and expired concentrations.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT00321191
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Philip J Peyton, MD FANZCA
Query!
Address
0
0
Austin Health
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT00321191
Download to PDF